title: A case series of paediatric hearing preservation cochlear implantation: a new treatment modality for children with drug-induced or congenital partial deafness.
abstract: OBJECTIVE
  To investigate the use of hearing preservation cochlear implantation in children with partial deafness.
  
  
  METHODS
  Five children with either drug-induced or congenital partial deafness were enrolled in a pilot study. The patients ranged in age from 13 months to 14 years. Implantation was performed using a hearing preservation technique. A Flex EAS electrode (MED-EL, Innsbruck, Austria) was used in all full insertions.
  
  
  RESULTS
  Low frequency hearing was preserved in all patients with postoperative bone conduction within 10 dB of the preoperative hearing levels. These changes were preserved over the follow-up period of 12 months. There were significant improvements in speech perception.
  
  
  CONCLUSIONS
  Hearing preservation cochlear implantation is a new effective modality in children with partial deafness.
authors: Department of Otolaryngology, Head and Neck Surgery, Fremantle Hospital, Fremantle, W.A., Australia.
authors: J
authors: J
authors: Kuthubutheen
authors: C N
authors: CN
authors: Hedne
authors: J
authors: J
authors: Krishnaswamy
authors: G P
authors: GP
authors: Rajan
mesh_terms: D000161:Acoustic Stimulation / Q000379:methods; D018262:Adenocarcinoma, Clear Cell / Q000188:drug therapy; D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects; D002528:Cerebellar Neoplasms / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D019929:Cochlear Implantation / Q000379:methods*; D003054:Cochlear Implants; D003638:Deafness / Q000139:chemically induced* / Q000151:congenital / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006044:Goiter, Nodular / Q000139:chemically induced / Q000151:congenital / Q000601:surgery; D006309:Hearing / Q000502:physiology; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced / Q000151:congenital / Q000601:surgery; D006801:Humans; D007223:Infant; D007680:Kidney Neoplasms / Q000188:drug therapy; D008297:Male; D010984:Platinum / Q000633:toxicity; D011446:Prospective Studies
chemical_list: D000970:Antineoplastic Agents; D010984:Platinum